Stuart Henderson

Connor Fox concentrates on clinical trial developments and emerging mesothelioma treatments. He translates dense medical study findings into accessible summaries, always noting sample sizes, trial phases, and study limitations. Connor pays close attention to how new therapies progress from early research to patient availability, and he flags when results are preliminary rather than conclusive. His writing style is measured and careful, avoiding overstatement of medical breakthroughs.

3 articles